Brevan Howard Capital Management’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.59M Buy
94,324
+82,208
+679% +$2.7M 0.02% 609
2026
Q1
$451K Buy
+12,116
New +$499K ﹤0.01% 1363
2024
Q4
Sell
-18,980
Closed -$744K 1188
2024
Q3
$744K Sell
18,980
-9,643
-34% -$349K 0.01% 557
2024
Q2
$921K Buy
28,623
+913
+3% +$29.4K 0.01% 405
2024
Q1
$913K Buy
27,710
+11,350
+69% +$394K 0.01% 293
2023
Q4
$568K Buy
+16,360
New +$564K 0.01% 425

Other funds holding G

Brevan Howard Capital Management's G Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Genpact (G) stake by 679% in Q2 2026, buying an estimated $2.7M and bringing the position to 94,324 shares worth $2.59M. The position accounts for 0.02% of the portfolio, ranked #609.

Brevan Howard Capital Management first reported a position in G in Q4 2023 and has held it in 6 quarters since. 478 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Brevan Howard Capital Management held 94,324 shares of Genpact worth $2.59M as of Q2 2026.
  • Brevan Howard Capital Management bought 82,208 Genpact shares in Q2 2026, an estimated $2.7M.
  • Genpact made up 0.02% of Brevan Howard Capital Management's portfolio in Q2 2026, its #609 holding.
  • Brevan Howard Capital Management first reported a position in Genpact in Q4 2023 and has held it in 6 quarters since.
  • 478 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.